Physician profile
Derek E Hamilton
NPI 1578582037
$6,696.37
in general payments reported to CMS, 2019-2025
14 companies · $583 in 2025
The $583 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,730 · 2020: $73.71 · 2021: $15.20 · 2022: $570 · 2023: $285 · 2024: $439 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $3,876.77 | 2019 | |
| Bausch & Lomb Americas INC. | $735.08 | 2022-2025 | Infuse, Miebo, Biotrue |
| Alcon Vision LLC | $389.93 | 2019-2024 | Total30 |
| Coopervision INC. | $361.13 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $224.81 | 2019-2021 | |
| Allergan, INC. | $199.08 | 2019-2022 | |
| Sight Sciences, INC. | $164.55 | 2019 | |
| Abb Con-Cise Optical Group LLC | $154.61 | 2019 | |
| Abbvie INC. | $149.74 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $142.09 | 2022 | |
| Biotissue Holdings INC. | $134.44 | 2023 | |
| Quidel Corporation | $77.65 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $44.20 | 2024-2025 | Xdemvy |
| Optos, INC. | $42.29 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.